ribavirin has been researched along with Bronchitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Kwong, JSW; Li, C; Shang, H; Sun, Y; Tao, L; Zhang, X; Zheng, R; Zhong, C | 1 |
| Faris, M; O'Riordan, T | 1 |
1 review(s) available for ribavirin and Bronchitis
| Article | Year |
|---|---|
Inhaled antimicrobial therapy.
Topics: Administration, Inhalation; Aerosols; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiviral Agents; Bronchitis; Colony Count, Microbial; Cystic Fibrosis; Humans; Lung Diseases; Pentamidine; Pneumonia, Pneumocystis; Respiration, Artificial; Ribavirin; Sputum; Tobramycin; Tracheitis | 1999 |
1 other study(ies) available for ribavirin and Bronchitis
| Article | Year |
|---|---|
Risk factors associated with the severity of adverse drug reactions by Xiyanping injection: A propensity score-matched analysis.
Topics: Adolescent; Adult; Aged; Andrographis; Antiviral Agents; Bronchitis; Child; Child, Preschool; Female; Herb-Drug Interactions; Humans; Infant; Infant, Newborn; Injections; Male; Middle Aged; Plant Extracts; Propensity Score; Ribavirin; Risk Factors; Young Adult | 2020 |